Variant report
Variant | esv3345768 |
---|---|
Chromosome Location | chr12:9292598-9297390 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:9289234..9291527-chr12:9295649..9297561,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7968546 | chr12:9292598-9292599 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs568950890 | chr12:9292671-9292672 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111937849 | chr12:9292764-9292765 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139194532 | chr12:9292840-9292841 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs199730308 | chr12:9292860-9292861 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191790103 | chr12:9292867-9292868 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79155291 | chr12:9292868-9292869 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs226365 | chr12:9292869-9292870 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs537873899 | chr12:9292885-9292886 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149933699 | chr12:9292931-9292932 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369652283 | chr12:9292965-9292966 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528213526 | chr12:9292989-9292990 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541976704 | chr12:9292998-9292999 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376088628 | chr12:9293050-9293051 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs80350460 | chr12:9293063-9293064 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182420929 | chr12:9293117-9293118 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140089572 | chr12:9293154-9293155 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11519086 | chr12:9293235-9293236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34283148 | chr12:9293308-9293309 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs373091142 | chr12:9293332-9293333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530566523 | chr12:9293374-9293375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185719793 | chr12:9293427-9293428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4367994 | chr12:9293474-9293475 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs190620261 | chr12:9293483-9293484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576937416 | chr12:9293509-9293510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570731611 | chr12:9293567-9293568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182483275 | chr12:9293575-9293576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73246344 | chr12:9293578-9293579 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs112684710 | chr12:9293593-9293594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533042692 | chr12:9293614-9293615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191022901 | chr12:9293655-9293656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539569489 | chr12:9293705-9293706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182365365 | chr12:9293770-9293771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556269012 | chr12:9293784-9293785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs61916035 | chr12:9293798-9293799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375327201 | chr12:9293846-9293847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541865573 | chr12:9293885-9293886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370515784 | chr12:9293889-9293890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562066556 | chr12:9293976-9293977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113803583 | chr12:9294063-9294064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187907885 | chr12:9294096-9294097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146811863 | chr12:9294142-9294143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193034565 | chr12:9294143-9294144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113498682 | chr12:9294145-9294146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs61916036 | chr12:9294192-9294193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185000248 | chr12:9294202-9294203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572657515 | chr12:9294211-9294212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187445885 | chr12:9294229-9294230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140543221 | chr12:9294266-9294267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34262551 | chr12:9294329-9294330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Epilepsy | 21858020 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Alzheimer''s disease | 17160897 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:9269000-9319200 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
2 | chr12:9280800-9310400 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr12:9291200-9296400 | Enhancers | Hela-S3 | cervix |
4 | chr12:9292200-9293200 | Strong transcription | Primary Natural Killer cells fromperipheralblood | blood |
5 | chr12:9293200-9303200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr12:9296000-9297000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr12:9296200-9296800 | Enhancers | Psoas Muscle | Psoas |
8 | chr12:9296200-9297000 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
9 | chr12:9296400-9297000 | ZNF genes & repeats | HSMMtube | muscle |
10 | chr12:9296400-9298000 | Flanking Active TSS | Hela-S3 | cervix |
11 | chr12:9296600-9297000 | Enhancers | Liver | Liver |
12 | chr12:9296800-9304200 | Weak transcription | Psoas Muscle | Psoas |
13 | chr12:9297000-9297400 | Weak transcription | HSMMtube | muscle |
14 | chr12:9297000-9298000 | Weak transcription | Liver | Liver |
15 | chr12:9297000-9299800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
16 | chr12:9297000-9316600 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |